Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

PTI | Mumbai | Updated: 13-07-2022 17:15 IST | Created: 13-07-2022 16:56 IST
Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal
Representative Image Image Credit: ANI
  • Country:
  • India

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

TRENDING

1
L'Oreal explores unloading chemical-related liabilities, WSJ reports

L'Oreal explores unloading chemical-related liabilities, WSJ reports

Global
2
Trump heads to Nebraska as Republicans defend Senate seat

Trump heads to Nebraska as Republicans defend Senate seat

Global
3
Trump signs order to expand access to tax-exempt diesel

Trump signs order to expand access to tax-exempt diesel

Global
4
Australia's ABC rejects AI copyright carveout, believes already been scraped

Australia's ABC rejects AI copyright carveout, believes already been scraped

Global

PERSPECTIVES AND INSIGHTS

Somalia’s Remittance Lifeline Breaks Down When Crisis Hits Everyone

AI Won’t Save the SDGs Alone, But It Could Build the Workforce That Can

From Imports to Industry: How Vietnam Built a Solar Export Powerhouse on Chinese Supply Chains

Can Social Protection Create Better Jobs? World Bank’s 500 Million Target Faces a Major Test

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026